Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer - Schiller, Joan H.; von Pawel, Joachim; Schütt, Philipp; Ansari, Rafat H.; Thomas, Michael; Saleh, Mansoor; McCroskey, Robert D.; Pfeifer, Wolfgang; Marsland, Thomas A.; Kloecker, Goetz H.; Sebastian, Martin; Pirker, Robert; et al. (Journal of thoracic oncology, 2010)
Gesehen am 07.06.2023